Clin2
NCT07332273Possibly a fitRecruiting

Levothyroxine for weight loss in obesity

Obesity

Treatments studied

Part of Hormones & metabolism clinical trials.

This trial tests whether adding levothyroxine (a thyroid hormone) to a low-calorie diet helps people with obesity lose more weight. It is for adults aged 25-60 with a BMI of 30-39.9 who have either mild underactive thyroid or normal thyroid but higher thyroid hormone levels in the normal range.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
286 people
Ages
25 years to 60 years
Study type
Interventional

Who can take part

  • You are between 25 and 60 years old.
  • Your body mass index (BMI) is between 30 and 39.9.
  • You have either very mild underactive thyroid (TSH 5-10) or normal thyroid with a TSH level in the upper part of the normal range.
  • If you are a woman who could become pregnant, you must use very effective birth control and not be pregnant or breastfeeding.
  • You do not have diabetes, active cancer, heart disease, or serious liver or kidney problems.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06143956Recruiting· Phase 2
Weight loss treatments for adults with obesity

This clinical trial tests new treatments for adults who are overweight or have obesity. The goal is to help people lose weight and improve their health.

Chandler, Arizona
NCT06809166Recruiting· Phase 4
Contrave for weight loss in adults with obesity

This study tests whether a weight loss medication called Contrave can help adults with obesity lose weight by changing how their body uses energy and handles food. If you qualify, you will take Contrave and be monitored for several months.

Ottawa, Ontario
NCT07467447Recruiting· Phase 2
Testing a weight-loss drug for people with obesity or overweight

This trial tests whether an experimental drug (LY3437943) can help people with obesity or overweight lose weight. It compares the drug to a placebo (inactive shot), and you must be willing to give yourself daily injections.

Shenzhen, Guangdong
NCT07738614Recruiting· Phase 1
Testing an investigational weight loss medicine for adults with overweight or obesity

This study tests an experimental medicine (eloralintide) to see if it can help people with overweight or obesity lose weight without having diabetes. The medicine works by affecting hormones that help control appetite and body weight.

San Antonio, Texas
NCT07321886Recruiting· Phase 3
Study of eloralintide for people with obesity or overweight

This trial tests if an investigational drug called eloralintide can help people with obesity or overweight lose weight. It is for people who do not have type 2 diabetes and who have tried but struggled to lose weight on their own.

Tuscaloosa, Alabama
NCT07665879Recruiting· Phase 1
Study of an experimental drug for people with overweight or obesity

This trial tests an experimental drug (Eloralintide) to see if it can help with weight management. It is for people who have a body mass index (BMI) between 25 and 45 and stable weight.

Neuss

Hear when a new Obesity trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.